Collagen vascular disease in the lungs

More documents

Recommendations

Info

SSc: 6MWT Conflict<strong>in</strong>g data on reproducibility Prognostic value unproven Wells. Sem Resp Crit Care Med 2007; 28: 379-88 Khanna et al. Curr Rheum Rev 2010; 6: 138-44
SSc: Exercise Test<strong>in</strong>g CPEX has been validated: >2x t Swigris et al. Thorax 2009; 64: 626-30
Page 1 and 2: COLLAGEN VASCULAR DISEASE IN THE LU
Page 3 and 4: Forms of Lung Disease in CVD • In
Page 5 and 6: ILD IN COLLAGEN VASCULAR DISEASE (C
Page 7 and 8: Antoniou et al. ERJ 2009; 33: 882-9
Page 9 and 10: NSIP: CXR • Bilateral • Fine re
Page 11 and 12: HRCT: UIP vs. NSIP
Page 13 and 14: Mean survivals of patients: HRCT di
Page 15 and 16: Background ILD common in SSc: 75% (
Page 17 and 18: CXR Limited value Imaging HRCT Very
Page 19 and 20: Serial PFTs & Prognosis: IPF Bad Pr
Page 21 and 22: Prognostic Algorithm Used 215 SSc-I
Page 23: 6MWT & Prognosis: IPF • Safe •
Page 27 and 28: Therapy 1) Prednisone ?? renal cris
Page 29 and 30: RHEUMATOID ARTHRITIS (RA)
Page 31 and 32: RA-ILD worse prognosis than other C
Page 33 and 34: PFTs Good at picking up lung diseas
Page 35 and 36: Therapy No randomised controlled tr
Page 37 and 38: ILD uncommon in SLE: Background •
Page 39 and 40: Lung Biopsy Not often done CIP: NSI
Page 41: Pulmonary Approach to CVD Patients

Collagen vascular disease in the lungs

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?